BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15460851)

  • 21. [Simvastatin-Induced Myopathy after Dose Increase].
    Kandzia I; Kowar M; Frackowiak M; Jacobs AH
    Dtsch Med Wochenschr; 2018 Dec; 143(24):1791-1794. PubMed ID: 30508862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simvastatin-associated memory loss.
    Orsi A; Sherman O; Woldeselassie Z
    Pharmacotherapy; 2001 Jun; 21(6):767-9. PubMed ID: 11401190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of Simvastatin and Risk of Acute Pancreatitis: A Nationwide Case-Control Study in Taiwan.
    Lin CM; Liao KF; Lin CL; Lai SW
    J Clin Pharmacol; 2017 Jul; 57(7):918-923. PubMed ID: 28301063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How common is rhabdomyolysis in patients receiving lipid-lowering therapy?
    Phillips PS
    Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):130-1. PubMed ID: 16265453
    [No Abstract]   [Full Text] [Related]  

  • 26. Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
    Rump LC; Baranova E; Okopien B; Weisskopf M; Kandra A; Ferber P
    Clin Ther; 2008 Oct; 30(10):1782-93. PubMed ID: 19014834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE; Ose L; Fraser N; Tribble DL; Quinto K; Reyes R; Johnson-Levonas AO; Sapre A; Donahue SR;
    Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statins as the new aspirin. Conclusions from the heart protection study were premature.
    Ravnskov U
    BMJ; 2002 Mar; 324(7340):789. PubMed ID: 11923169
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y
    Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia.
    Davidson MH; Stein EA; Hunninghake DB; Ose L; Dujovne CA; Insull W; Bertolami M; Weiss SR; Kastelein JJ; Scott RS; Campodónico S; Escobar ID; Schrott HG; Bays H; Stepanavage ME; Wu M; Tate AC; Melino MR; Kush D; Mercuri M; Mitchel YB;
    Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):253-62. PubMed ID: 11213534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of simvastatin/ezetimibe 10/10 mg versus simvastatin 40 mg on serum vitamin D levels.
    Liberopoulos EN; Makariou SE; Moutzouri E; Kostapanos MS; Challa A; Elisaf M
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):229-33. PubMed ID: 23288870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia.
    Yoon HS; Kim SH; Kim JK; Ko SH; Ko JE; Park SJ; Park MG; Lee JH; Hyon MS
    Ann Pharmacother; 2011 Jul; 45(7-8):841-9. PubMed ID: 21693699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone-replacement therapy compared with simvastatin for postmenopausal women with hypercholesterolemia.
    Pines A; Levo Y; Ayalon D
    N Engl J Med; 1998 Jan; 338(1):63; author reply 64. PubMed ID: 9424571
    [No Abstract]   [Full Text] [Related]  

  • 34. Ezetimibe/simvastatin.
    Montecucco F; Quercioli A; Mach F
    Expert Opin Drug Saf; 2009 Nov; 8(6):715-25. PubMed ID: 19968571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical reasoning: rhabdomyolysis after combined treatment with simvastatin and fluconazole.
    Findling O; Meier N; Sellner J; Nedeltchev K; Arnold M
    Neurology; 2008 Oct; 71(15):e34-7. PubMed ID: 18838657
    [No Abstract]   [Full Text] [Related]  

  • 36. Simvastatin-induced bilateral leg compartment syndrome and myonecrosis associated with hypothyroidism.
    Ramdass MJ; Singh G; Andrews B
    Postgrad Med J; 2007 Mar; 83(977):152-3. PubMed ID: 17344566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute pancreatitis associated with combined lisinopril and atorvastatin therapy.
    Kanbay M; Sekuk H; Yilmaz U; Gur G; Boyacioglu S
    Dig Dis; 2005; 23(1):92-4. PubMed ID: 15920330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J; Hoffman R; Hanson M; Veltri E
    Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
    Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A woman with axillary red-brown plaques.
    Brouwer MW; Kemperman PM
    Br J Dermatol; 2014 Feb; 170(2):479-80. PubMed ID: 24205979
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.